

NANDROLONE PHENYLPROPIONATE 150 MG INJECTION
Drug Class: Androgen; Anabolic Steroid; Androgen Ester; Progestogen
Composition:
- Active Substance: Nandrolone Phenylpropionate
- Concentration: 150 mg/mL
Presentation: 10 mL Vial
Manufacturer: Dragon Pharma
Common Name(s): Durabolin, Fenobolin, Activin, Deca-Durabolin, Evabolin, Grothic, Hybolin Improved, Metabol, Nerobolil, Neurabol, Norabol, Noralone, Sintabolin, Strabolene, Superanabolon, Turinabol
Tested in Laboratory: View Lab Report
NPP 150 by Dragon Pharma delivers Nandrolone Phenylpropionate at 150 mg/mL, offering a faster-acting alternative to Deca for users seeking rapid anabolic response. Its short ester allows it to kick in within days, making it ideal for shorter cycles, contest prep, or lean bulking phases.
NPP supports high-quality lean mass gains, improves nitrogen retention, and enhances recovery through increased collagen synthesis and joint lubrication. It's often used by athletes who need a fast-acting compound with less water retention than Deca. Research has confirmed nandrolone's therapeutic effects on joint pain and muscle wasting, making it popular during both bulking and injury-recovery cycles.
For a lean mass cycle, NPP 150 is often combined with:
For a mass-building cycle, common stacks include:
Advanced users often reference cycle strategies using short-acting nandrolones to maximize absorption and minimize suppression.
Possible side effects include oily skin, high blood pressure, estrogenic effects like water retention or gynecomastia, and testosterone suppression. Post-cycle therapy is strongly advised using Clomid or Nolvadex.
NPP 150 mg is used for building lean muscle mass, improving joint support, and speeding up recovery. It's a fast-acting nandrolone ester ideal for shorter cycles or contest prep.
NPP 150 should be injected every other day (EOD) due to its short half-life. A common schedule includes three injections per week, such as Monday, Wednesday, and Friday.
Possible side effects include water retention, acne, increased blood pressure, gynecomastia, and testosterone suppression. Using an aromatase inhibitor and PCT is advised.
Yes. NPP stacks well with Testosterone Propionate, Winstrol, Anavar, or even Dianabol and Anadrol for more advanced bulking cycles. It's highly versatile in both cutting and mass-building cycles.
Yes, Dragon Pharma NPP 150 has undergone lab testing. The April 2024 report confirmed its potency and purity at 150 mg/mL as labeled.
Please log in to write NPP 150 mg review.
NANDROLONE DECANOATE 300 MG INJECTION
Drug Class: Androgen; Anabolic Steroid; Progestogen
Composition:
- Active Substance: Nandrolone Decanoate
- Concentration: 300 mg/mL
Presentation: 10 mL Vial
Manufacturer: Dragon Pharma
Common Name(s): Deca-Durabolin, Deca-Durabol, Decaneurabol, Metadec, Retabolil
Tested in Laboratory: View Lab Report
BOLDENONE UNDECYLENATE 300 MG INJECTION
Drug Class: Androgen; Anabolic Steroid; Androgen Ester
Composition:
- Active Substance: Boldenone Undecylenate
- Concentration: 300 mg/mL
Presentation: 10 mL Vial
Manufacturer: Dragon Pharma
Common Name(s): Boldane, Equipoise, Parenabol, Vebonol
METHENOLONE ENANTHATE 100 MG INJECTION
Drug Class: Androgen; Anabolic Steroid; Androgen Ester
Composition:
- Active Substance: Methenolone Enanthate
- Concentration: 100 mg/mL
Presentation: 10 mL Vial
Manufacturer: Dragon Pharma
Common Name: Primobolan Depot
Tested in Laboratory: View Lab Report
TRENBOLONE ACETATE 100 MG INJECTION
Drug Class: Androgen; Anabolic Steroid; Androgen Ester; Progestogen
Composition:
- Active Substance: Trenbolone Acetate
- Concentration: 100 mg/mL
Presentation: 10 mL Vial
Manufacturer: Dragon Pharma
Common Name(s): Revalor, Finaplix, Finajet, RU-1697
Tested in Laboratory: View Lab Report
TRENBOLONE ENANTHATE 200 MG INJECTION
Drug Class: Androgen; Anabolic Steroid; Androgen Ester; Progestogen
Composition:
- Active Substance: Trenbolone Enanthate
- Concentration: 200 mg/mL
Presentation: 10 mL Vial
Manufacturer: Dragon Pharma
Common Name(s): Trenabol, Trenbolone Heptanoate
Tested in Laboratory: View Lab Report